EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SGLT2 Inhibition, Blood Lipids, and Cardiovascular Disease: A Mendelian Randomization Study

Jiangtao Li, Chenhe Li, Xin Feng, Xiang Wei

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Jiangtao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Sodium-Glucose Transporter 2 Inhibitors, Cardiovascular Diseases, Lipids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aim to investigate the causal effect of blood lipids mediating sodium-glucose cotransporter 2 (SGLT2) inhibition in cardiovascular disease (CVD) using Mendelian randomization (MR). Methods and results A two-sample two-step MR study was conducted to evaluate the association of SGLT2 inhibition with CVDs and the mediation effects of blood lipids linking SGLT2 inhibition with CVDs. Genetic instruments for SGLT2 inhibition were identified as genetic variants, which were associated with the expression of the SLC5A2 gene and glycated haemoglobin level (HbA1c). SGLT2 inhibition was associated with reduced risk of heart failure (HF) (OR 0.44 [95% CI 0.32–0.61]; P = 6.0 × 10−7), atrial fibrillation (AF) (0.47 [0.37–0.61]; P = 1.81 × 10−8), coronary artery disease (CAD) (0.47 [0.30–0.73]; P = 7.46 × 10−4), myocardial infarction (MI) (0.30 [0.15–0.61]; P = 7.44 × 10−4), any stroke (AS) (0.28 [0.18–0.42]; P = 1.14 × 10−9), and ischaemic stroke (IS) (0.27 [0.17–0.44]; P = 1.97 × 10−7). Our results indicated that the proportion mediated of the mediating effect of total cholesterol was 1.7% (OR 0.99 [95% CI 0.98, 0.99], P = 0.004), 4.7% (0.96 [0.95, 0.98], P = 0.002), and 2.7% (0.97 [0.95, 0.98], P = 0.002) in the association between SGLT2 inhibition and the risk of HF, CAD, and MI, respectively. For low-density lipoprotein cholesterol, the proportion mediated of the mediating effect was 2.2% for HF (OR 0.98 [95% CI 0.98, 0.99], P = 0.003), 8.6% for CAD (0.93 [0.91, 0.95], P = 5.74 × 10−4), and 5.0% for MI (0.95 [0.94, 0.96], P = 6.97 × 10−4). For non-high-density lipoprotein cholesterol, the proportion mediated of the mediating effect was 3.4% for HF (OR 0.98 [95% CI 0.97, 0.98], P = 4.42 × 10−6), 11.8% for CAD (0.92 [0.90, 0.93], P = 7.23 × 10−8), 5.7% for MI (0.94 [0.92, 0.95], P = 8.17 × 10−7), 1.5% for AS (0.98 [0.98, 0.99], P = 0.001), and 1.4% for IS (0.98 [0.98, 0.99], P = 0.004).

Conclusions

Our study showed the association of SGLT2 inhibition with the reduced risk of CVDs and blood lipids might mediate this association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisSodium-Glucose Transporter 2 InhibitorsCardiovascular DiseasesLipidsDiabetes Mellitus, Type 2HumansSodium-Glucose Transporter 2Male

Stichwörter der Autor:innen

Blood lipidCardiovascular diseaseMendelian randomizationSodium‐glucose cotransporter 2 inhibition

Substanzen

Sodium-Glucose Transporter 2 InhibitorsLipidsSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, China.
  • NHC Key Laboratory of Organ Transplantation, Ministry of Health, Wuhan, China.

Zitieren

APA

Li, J., Li, C., Feng, X., & Wei, X. (2024). SGLT2 Inhibition, Blood Lipids, and Cardiovascular Disease: A Mendelian Randomization Study. ESC Heart Failure. https://doi.org/10.1002/ehf2.14987

Vancouver

Li J, Li C, Feng X, Wei X. SGLT2 Inhibition, Blood Lipids, and Cardiovascular Disease: A Mendelian Randomization Study. ESC Heart Failure. 2024. doi:10.1002/ehf2.14987

BibTeX
@article{Li2024,
  author = {Li, Jiangtao and Li, Chenhe and Feng, Xin and Wei, Xiang},
  title = {SGLT2 Inhibition, Blood Lipids, and Cardiovascular Disease: A Mendelian Randomization Study},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14987}
}
Kostenlos starten →